Food, drugs, devices › Baxter Healthcare Corp
Device recall: Baxter Amia Automated Peritoneal Dialysis Set with Cassette, REF 5C5479
FDA enforcement event 78085 is a device recall by Baxter Healthcare Corp of Mountain Home, AR, initiated 1 Sep 2017 and classified Class II, with 1 product record.
FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 93% of the 1,091 device enforcement events initiated in 2017 carry the same class.
Status: Terminated, terminated 27 Aug 2019. Initiation: voluntary: firm initiated. Baxter Healthcare Corp has 83 enforcement events on this register, with a median of 1 product record per event.
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Baxter Healthcare Corp, Mountain Home, AR.
Reason for recall
"The firm received increased customer complaints for Missing Red Line, Patient Slow Flow, Solution Slow Flow, and Inadequate Drain alerts on certain lots of the AMIA Automated Peritoneal Dialysis Set with Cassette."
Distribution
"nationwide, Canada"
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| Z-3133-2017 | Baxter Amia Automated Peritoneal Dialysis Set with Cassette, REF 5C5479 | 164,700 units | Class II | Terminated | 20 Sep 2017 |
Context
Other enforcement events for Baxter Healthcare Corp
All 83 events for Baxter Healthcare Corp
Questions and answers
Why was this device recalled?
FDA's record gives the reason for recall as: "The firm received increased customer complaints for Missing Red Line, Patient Slow Flow, Solution Slow Flow, and Inadequate Drain alerts on certain lots of the AMIA Automated Peritoneal Dialysis Set with Cassette."
What does Class II mean?
FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Where was the product distributed?
FDA's distribution pattern field reads: "nationwide, Canada"
Is the recall still ongoing?
FDA lists the status as Terminated; the termination date is 27 Aug 2019. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.